HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 69 filers reported holding HILLEVAX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,557,502 | -13.0% | 799,274 | 0.0% | 2.42% | +17.7% |
| Q1 2024 | $13,291,927 | +3.6% | 799,274 | 0.0% | 2.06% | +3.0% |
| Q4 2023 | $12,828,348 | +19.3% | 799,274 | 0.0% | 2.00% | -39.3% |
| Q3 2023 | $10,750,235 | +4.4% | 799,274 | +33.4% | 3.29% | +82.0% |
| Q2 2023 | $10,301,520 | +2.2% | 599,274 | -1.7% | 1.81% | -13.2% |
| Q1 2023 | $10,081,019 | -1.2% | 609,862 | -0.0% | 2.08% | -5.1% |
| Q4 2022 | $10,206,337 | -2.1% | 610,062 | 0.0% | 2.20% | -9.6% |
| Q3 2022 | $10,426,000 | +25.1% | 610,062 | -20.0% | 2.43% | +9.4% |
| Q2 2022 | $8,335,000 | – | 762,577 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,285,682 | $101,493,000 | 9.58% |
| Qiming U.S. Ventures Management, LLC | 558,923 | $6,109,000 | 8.48% |
| Abingworth LLP | 1,838,486 | $19,929,000 | 6.38% |
| Samsara BioCapital, LLC | 762,577 | $8,335,000 | 2.22% |
| SEVEN GRAND MANAGERS, LLC | 34,386 | $376,000 | 0.85% |
| StepStone Group LP | 676,567 | $7,395,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,617,948 | $28,614,000 | 0.59% |
| RA Capital Management | 1,760,019 | $19,237,000 | 0.51% |
| Perceptive Advisors | 764,907 | $8,360,000 | 0.26% |
| BVF INC/IL | 382,513 | $4,181,000 | 0.20% |